Structural basis of PPARγ-mediated transcriptional repression by the covalent inverse agonist FX-909

Zane T Laughlin1, Liudmyla Arifova1,2, Paola Munoz-Tello1

  • 1Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, United States 37232.

Insights

FX-909, a novel drug, effectively inhibits bladder cancer growth by repressing peroxisome proliferator-activated receptor gamma (PPARγ) activity. This compound shows improved selectivity and stabilization of a transcriptionally repressive PPARγ conformation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Hyperactivation of peroxisome proliferator-activated receptor gamma (PPARγ) drives urothelial cancer growth.
  • Pharmacological inhibition of PPARγ is a therapeutic strategy for bladder cancer.
  • FX-909 is an investigational covalent PPARγ inverse agonist for advanced solid tumors, including bladder cancer.

Purpose of the Study:

  • To compare the mechanism of action of FX-909 with other covalent PPARγ inverse agonists.
  • To elucidate the structural basis for FX-909's selective inverse agonism.
  • To highlight the clinical relevance of transcriptionally repressive PPARγ inverse agonists.

Main Methods:

  • Functional profiling assays.
  • Nuclear Magnetic Resonance (NMR) spectroscopy.
  • Crystallography of the PPARγ ligand-binding domain (LBD) complexed with FX-909 and a corepressor peptide.

Main Results:

  • FX-909 exhibits enhanced corepressor-selective inverse agonism compared to T0070907.
  • FX-909 more effectively stabilizes a transcriptionally repressive PPARγ LBD conformation.
  • Structural analysis revealed a shared repressive conformation among covalent inverse agonists.

Conclusions:

  • FX-909 demonstrates improved pharmacological properties as a PPARγ inverse agonist.
  • The findings support the development of transcriptionally repressive PPARγ inverse agonists for cancer therapy.
  • FX-909's mechanism is crucial for its potential in treating muscle-invasive bladder cancer.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.5K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
22.1K